221 related articles for article (PubMed ID: 31017095)
1. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
[TBL] [Abstract][Full Text] [Related]
2. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.
Kim SP; Tilburt JC; Shah ND; Yu JB; Konety B; Nguyen PL; Abouassaly R; Williams SB; Gross CP
Clin Genitourin Cancer; 2019 Jun; 17(3):e472-e481. PubMed ID: 30827923
[TBL] [Abstract][Full Text] [Related]
3. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.
Bukavina L; Tilburt JC; Konety B; Shah ND; Gross CP; Yu JB; Schumacher F; Kutikov A; Smaldone MC; Kim SP
Eur Urol Focus; 2020 Mar; 6(2):273-279. PubMed ID: 30219709
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
[TBL] [Abstract][Full Text] [Related]
5. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists.
Kim SP; Meropol NJ; Gross CP; Tilburt JC; Konety B; Yu JB; Abouassaly R; Weight CJ; Williams SB; Shah ND
Urol Oncol; 2018 Nov; 36(11):501.e15-501.e21. PubMed ID: 30190177
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
[TBL] [Abstract][Full Text] [Related]
7. Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey.
Puneet K; Tilburt JC; Volk RJ; Bennett CL; Qureshi Z; Gershman B; Sedlacek HM; Kim SP
Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13301. PubMed ID: 33112008
[TBL] [Abstract][Full Text] [Related]
8. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
[TBL] [Abstract][Full Text] [Related]
9. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.
Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Thompson RH; Han LC; Shah ND; Smaldone MC; Gross CP; Frank I; Weight CJ; Beebe TJ; Tilburt JC
BJU Int; 2014 May; 113(5b):E106-11. PubMed ID: 24053213
[TBL] [Abstract][Full Text] [Related]
10. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
11. Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients.
Xu J; Bock C; Janisse J; Schwartz KL; Triest J; Cher ML; Goodman M
Urology; 2021 Sep; 155():83-90. PubMed ID: 33482128
[TBL] [Abstract][Full Text] [Related]
12. Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-Risk" Prostate Cancer: Implications for Active Surveillance.
Morlacco A; Cheville JC; Rangel LJ; Gearman DJ; Karnes RJ
Eur Urol; 2017 Sep; 72(3):442-447. PubMed ID: 27574819
[TBL] [Abstract][Full Text] [Related]
13. Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.
Yang DD; Mahal BA; Muralidhar V; Nezolosky MD; Vastola ME; Labe SA; Boldbaatar N; King MT; Martin NE; Orio PF; Beard CJ; Hoffman KE; Trinh QD; Spratt DE; Feng FY; Nguyen PL
Eur Urol Focus; 2019 Jan; 5(1):69-76. PubMed ID: 28753811
[TBL] [Abstract][Full Text] [Related]
14. Physician Perception of Grade Group 1 Prostate Cancer.
Saoud R; Woranisarakul V; Paner GP; Ramotar M; Berlin A; Cooperberg M; Eggener SE
Eur Urol Focus; 2023 Nov; 9(6):966-973. PubMed ID: 37117112
[TBL] [Abstract][Full Text] [Related]
15. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
Philippou Y; Raja H; Gnanapragasam VJ
BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
[TBL] [Abstract][Full Text] [Related]
16. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
[TBL] [Abstract][Full Text] [Related]
17. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
[TBL] [Abstract][Full Text] [Related]
18. Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.
Loeb S; Folkvaljon Y; Curnyn C; Robinson D; Bratt O; Stattin P
JAMA Oncol; 2017 Oct; 3(10):1393-1398. PubMed ID: 27768168
[TBL] [Abstract][Full Text] [Related]
19. Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice.
Herden J; Weissbach L
World J Urol; 2018 Mar; 36(3):383-391. PubMed ID: 29330583
[TBL] [Abstract][Full Text] [Related]
20. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery.
Tosoian JJ; Sundi D; Trock BJ; Landis P; Epstein JI; Schaeffer EM; Carter HB; Mamawala M
Eur Urol; 2016 Apr; 69(4):576-581. PubMed ID: 26456680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
